166 related articles for article (PubMed ID: 31524358)
1. Glycopyrronium (Qbrexza) Topical Wipes for Hyperhidrosis.
Arnold MJ; O'Connor C
Am Fam Physician; 2019 Sep; 100(6):372-373. PubMed ID: 31524358
[No Abstract] [Full Text] [Related]
2. Qbrexza - A glycopyrronium cloth for axillary hyperhidrosis.
Med Lett Drugs Ther; 2019 Jan; 61(1564):10-11. PubMed ID: 30856158
[No Abstract] [Full Text] [Related]
3. Glycopyrronium Tosylate (Qbrexza) for Hyperhidrosis.
Nwannunu CE; Limmer AL; Coleman K; Shah R; Patel RR; Mui UN; Tyring SK
Skin Therapy Lett; 2019 Mar; 24(2):1-3. PubMed ID: 30970203
[TBL] [Abstract][Full Text] [Related]
4. A 44-Week Open-Label Study Evaluating Safety and Efficacy of Topical Glycopyrronium Tosylate in Patients with Primary Axillary Hyperhidrosis.
Glaser DA; Hebert AA; Nast A; Werschler WP; Green L; Mamelok RD; Quiring J; Drew J; Pariser DM
Am J Clin Dermatol; 2019 Aug; 20(4):593-604. PubMed ID: 31111409
[TBL] [Abstract][Full Text] [Related]
5. Use of oral glycopyrronium bromide in hyperhidrosis.
Bajaj V; Langtry JA
Br J Dermatol; 2007 Jul; 157(1):118-21. PubMed ID: 17459043
[TBL] [Abstract][Full Text] [Related]
6. Use of gloves when applying topical glycopyrronium for treatment of primary axillary hyperhidrosis.
Siscos SM; Figenshau K; Rajpara A
J Am Acad Dermatol; 2020 Oct; 83(4):e275. PubMed ID: 31846717
[No Abstract] [Full Text] [Related]
7. Limited Systemic Exposure with Topical Glycopyrronium Tosylate in Primary Axillary Hyperhidrosis.
Pariser DM; Lain EL; Mamelok RD; Drew J; Mould DR
Clin Pharmacokinet; 2021 May; 60(5):665-676. PubMed ID: 33433785
[TBL] [Abstract][Full Text] [Related]
8. Topical Glycopyrronium Tosylate in Primary Axillary Hyperhidrosis: A Profile of Its Use.
Lamb YN
Clin Drug Investig; 2019 Nov; 39(11):1141-1147. PubMed ID: 31571127
[TBL] [Abstract][Full Text] [Related]
9. Use of topical 2.4% glycopyrronium tosylate in familial benign pemphigus (Hailey-Hailey disease).
Bindernagel R; Kimmis BD; Liu D
Dermatol Online J; 2020 Oct; 26(10):. PubMed ID: 33147680
[No Abstract] [Full Text] [Related]
10. Reversible anisocoria due to inadvertent ocular exposure to topical anticholinergic treatment for primary axillary hyperhidrosis.
Pashaei-Marandi A; Assam JH; Arnold A; Lee AG; Bonelli L
Can J Ophthalmol; 2019 Dec; 54(6):e300-e302. PubMed ID: 31836120
[No Abstract] [Full Text] [Related]
11. A new medication, a new toxidrome - A case report of anticholinergic wipe toxicity due to improper medication use.
Michael T; Paul C
Am J Emerg Med; 2021 Aug; 46():797.e1-797.e2. PubMed ID: 33583621
[TBL] [Abstract][Full Text] [Related]
12. Topical glycopyrronium tosylate for the treatment of primary axillary hyperhidrosis: Results from the ATMOS-1 and ATMOS-2 phase 3 randomized controlled trials.
Glaser DA; Hebert AA; Nast A; Werschler WP; Green L; Mamelok R; Drew J; Quiring J; Pariser DM
J Am Acad Dermatol; 2019 Jan; 80(1):128-138.e2. PubMed ID: 30003988
[TBL] [Abstract][Full Text] [Related]
13. Pharmacologic anisocoria secondary to topical glycopyrronium for axillary hyperhidrosis: an emerging clinical presentation.
Kaufman AR; Gulati S; Curnyn KM
Can J Ophthalmol; 2020 Oct; 55(5):464. PubMed ID: 32735775
[No Abstract] [Full Text] [Related]
14. The efficacy of oral anticholinergics for sympathetic overactivity in a thoracic surgery clinic.
Hynes CF; Seevaratnam S; Gesuwan K; Margolis M; Marshall MB
J Thorac Cardiovasc Surg; 2016 Aug; 152(2):565-8. PubMed ID: 27160942
[TBL] [Abstract][Full Text] [Related]
15. Dilated pupils caused by topical glycopyrrolate for hyperhidrosis.
Panting KJ; Alkali AS; Newman WD; Sharpe GR
Br J Dermatol; 2008 Jan; 158(1):187-8. PubMed ID: 17944977
[No Abstract] [Full Text] [Related]
16. Urinary retention caused by topical glycopyrrolate for hyperhidrosis.
Madan V; Beck MH
Br J Dermatol; 2006 Sep; 155(3):634-5. PubMed ID: 16911300
[No Abstract] [Full Text] [Related]
17. Pharmacologic mydriasis in an infant following parental use of topical glycopyrronium tosylate.
Seto S; Teo AA; Walsh RD
J AAPOS; 2019 Dec; 23(6):359-361. PubMed ID: 31683011
[TBL] [Abstract][Full Text] [Related]
18. Craniofacial hyperhidrosis successfully treated with topical glycopyrrolate.
Luh JY; Blackwell TA
South Med J; 2002 Jul; 95(7):756-8. PubMed ID: 12144084
[TBL] [Abstract][Full Text] [Related]
19. Variables Affecting Delivery of Glycopyrronium Tosylate Through Human Skin In Vitro.
Caserta F; Lenn J; Hofland H
J Drugs Dermatol; 2020 Nov; 19(11):1080-1085. PubMed ID: 33196749
[TBL] [Abstract][Full Text] [Related]
20. Treatment of compensatory gustatory hyperhidrosis with topical glycopyrrolate.
Kim WO; Kil HK; Yoon DM; Cho MJ
Yonsei Med J; 2003 Aug; 44(4):579-82. PubMed ID: 12950111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
